Author:
Tian Xixi,Zhang Shengzheng,Zhang Qiong,Kang Licheng,Ma Changzhen,Feng Lifeng,Li Shengyu,Li Jing,Yang Liang,Liu Jie,Qi Zhi,Shen Yanna
Funder
National Natural Science Foundation of China
Tianjin Natural Science Foundation
Key Laboratory of Emergency and Trauma
Ministry of Education
Fundamental Research Funds for the Central Universities
Subject
Clinical Biochemistry,Nutrition and Dietetics,Molecular Biology,Biochemistry,Endocrinology, Diabetes and Metabolism
Reference46 articles.
1. Incidence and mortality of kidney cancers, and human development index in Asia; a matter of concern;Arabsalmani;J Nephropathol,2017
2. Cancer statistics, 2019;Siegel;CA Cancer J Clin,2019
3. Systemic therapy of metastatic renal cell carcinoma: Review of the current literature;Zerdes;Urologia,2019
4. Highlights in kidney cancer from the American Society of Clinical Oncology Genitourinary Cancers Symposium;Figlin;Clin Adv Hematol Oncol,2018
5. Allard CB, Gelpi-Hammerschmidt F, Harshman LC, Choueiri TK, Faiena I, Modi P, Chung BI, Tinay I, Singer EA, Chang SL: Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States. Urol Oncol 2015, 33(11):496 e411-496.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献